Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease

Area of Science:

• Nephrology
• Immunology
• Genetics

Background:

• Minimal Change Disease (MCD) presents as acute nephrotic syndrome with minimal histological renal changes and good steroid response.
• Frequent MCD relapses and steroid dependence can lead to disease progression to focal and segmental glomerulosclerosis (FSGS).
• Distinguishing between MCD and FSGS is challenging due to overlapping molecular mechanisms and occasional genetic similarities.

Purpose of the Study:

• To explore the shared molecular mechanisms and potential triggers underlying Minimal Change Disease (MCD) and its evolution to focal and segmental glomerulosclerosis (FSGS).
• To evaluate the utility of animal models in understanding the progression from MCD to FSGS.
• To discuss the potential role of genetic analysis and various molecular pathways in defining MCD as a distinct clinical-pathological-genetic entity.

Main Methods:

• Review of existing literature on Minimal Change Disease (MCD) and focal and segmental glomerulosclerosis (FSGS).
• Analysis of findings from various animal models of proteinuria and glomerular damage (e.g., Puromycin Aminonucleoside, Adriamycin nephrosis, Buffalo/Mna rats, Lipopolysaccharide nephropathy).
• Discussion of proposed molecular mechanisms, including the role of cytokines, immune cells (T/Treg/B cells), and specific molecules (B7-1, CD40/CD40L, TNF, etc.).

Main Results:

• Animal models partially mimic the evolution from MCD to FSGS, often linked to persistent proteinuria.
• Specific rat strains (Buffalo/Mna) offer clearer insights into MCD evolution due to Th2 cytokine overexpression.
• While various molecules and cytokines are implicated, a single causative factor for MCD is unlikely; an interactive process is suggested.

Conclusions:

• Animal models are crucial for studying the progression from MCD to FSGS, particularly concerning persistent proteinuria.
• The interplay of multiple factors including oxidants, cytokines (Th2, Th17), immune cells (Tregs, B cells), and molecules (B7-1, CD40/CD40L, TNF, etc.) is likely involved in MCD pathogenesis.
• Whole genome sequencing may help establish specific genetic features to define MCD as a distinct clinical-pathology-genetic entity, aiding differentiation from FSGS.